310 related articles for article (PubMed ID: 7514955)
21. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer.
Inoue H; Mizuno M; Uesu T; Ueki T; Tsuji T
Acta Med Okayama; 1994 Oct; 48(5):271-7. PubMed ID: 7532345
[TBL] [Abstract][Full Text] [Related]
22. Complement activation and regulator expression after anoxic injury of human endothelial cells.
Väkevä A; Meri S
APMIS; 1998 Dec; 106(12):1149-56. PubMed ID: 10052723
[TBL] [Abstract][Full Text] [Related]
23. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).
Rautemaa R; Meri S
J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
25. Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis.
Bjørge L; Junnikkala S; Kristoffersen EK; Hakulinen J; Matre R; Meri S
Br J Cancer; 1997; 75(9):1247-55. PubMed ID: 9155042
[TBL] [Abstract][Full Text] [Related]
26. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
27. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
28. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
29. Complement regulatory proteins in the salivary glands and saliva of Sjögren's syndrome patients and healthy subjects.
Cuida M; Legler DW; Eidsheim M; Jonsson R
Clin Exp Rheumatol; 1997; 15(6):615-23. PubMed ID: 9444417
[TBL] [Abstract][Full Text] [Related]
30. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract.
Berstad AE; Brandtzaeg P
Gut; 1998 Apr; 42(4):522-9. PubMed ID: 9616315
[TBL] [Abstract][Full Text] [Related]
31. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion.
Jensen TS; Bjørge L; Wollen AL; Ulstein M
Am J Reprod Immunol; 1995 Jul; 34(1):1-9. PubMed ID: 7576125
[TBL] [Abstract][Full Text] [Related]
32. Enhanced expression of decay-accelerating factor and CD59/homologous restriction factor 20 in intestinal metaplasia, gastric adenomas and intestinal-type gastric carcinomas but not in diffuse-type carcinomas.
Kiso T; Mizuno M; Nasu J; Shimo K; Uesu T; Yamamoto K; Okada H; Fujita T; Tsuji T
Histopathology; 2002 Apr; 40(4):339-47. PubMed ID: 11943018
[TBL] [Abstract][Full Text] [Related]
33. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063
[TBL] [Abstract][Full Text] [Related]
34. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
36. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
van Beek J; van Meurs M; 't Hart BA; Brok HP; Neal JW; Chatagner A; Harris CL; Omidvar N; Morgan BP; Laman JD; Gasque P
J Immunol; 2005 Feb; 174(4):2353-65. PubMed ID: 15699172
[TBL] [Abstract][Full Text] [Related]
37. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
[TBL] [Abstract][Full Text] [Related]
38. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
[TBL] [Abstract][Full Text] [Related]
39. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]